The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term off-label MAPK inhibitor therapy in children with severe/refractory Langerhans cell histiocytosis: An international observational study of 277 cases.
 
Jean Donadieu
No Relationships to Disclose
 
Dmitry Evseev
No Relationships to Disclose
 
Caroline Hutter
No Relationships to Disclose
 
France Pegoraro
No Relationships to Disclose
 
Elena Sieni
No Relationships to Disclose
 
Olga Slater
No Relationships to Disclose
 
Cor Van Den Bos
No Relationships to Disclose
 
Cecile Adam
No Relationships to Disclose
 
Myriam Ben Arush
No Relationships to Disclose
 
Thomas Lehrnbecher
No Relationships to Disclose
 
Itziar Astigarraga
No Relationships to Disclose
 
Guido Felizzia
No Relationships to Disclose
 
Michael Maschan
No Relationships to Disclose
 
Anna Raciborska
No Relationships to Disclose
 
Karel Svojgr
No Relationships to Disclose
 
Islam Amine Larabi
No Relationships to Disclose
 
Jean-François Emile
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Deciphera; HalioDx; Merck Serono; MSD Oncology; Novartis; Pierre Fabre; Qiagen; Recordati; Recordati
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - MSD Oncology
 
Jan-Inge Henter
No Relationships to Disclose
 
Sébastien Héritier
No Relationships to Disclose
 
Milen Minkov
No Relationships to Disclose
 
The European Consortium for Histiocytosis (ECHO)
No Relationships to Disclose